🇺🇸 FDA
Pipeline program

TEV-53408

TV53408-IMM-10209

Phase 1 small_molecule active

Quick answer

TEV-53408 for Vitiligo is a Phase 1 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Vitiligo
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials